PascualLab Marks Milestone With Dual Launch
2026-09-01
Anniversaries usually look backward; PascualLab is using its milestone to redraw its business map. Marking eight decades in the pharmaceutical market, the company is introducing Alevia-B and Mycolla C, pairing a mobility-focused supplement with a beauty and personal care entrant to stretch its health and wellness portfolio beyond traditional prescriptions.
The bolder move sits in mobility. By positioning Alevia-B around joint comfort and neuromuscular support, PascualLab is signaling that orthopedics and physical rehabilitation are no longer the exclusive domain of hospitals but fertile ground for over-the-counter intervention, where consumer brands can leverage compliance-friendly dosage forms and vitamin B complex formulations to reach ageing and active populations alike.
Equally telling is the push into aesthetics. With Mycolla C, the company links dermatology concepts such as collagen synthesis and antioxidant activity to a mass-market beauty narrative, betting that consumers now treat skin, hair, and nails as part of preventive medicine rather than vanity. This dual launch suggests that, for PascualLab, the border between therapy and lifestyle has become a commercial seam worth mining.
Loading...
